Tchaikapharma Highquality Medicines AD 

€8.40
0
+€0.15+1.82%Wednesday 06:02

Statistics

Day High
8.4
Day Low
8.4
52W High
9.15
52W Low
5.4
Volume
-
Avg. Volume
-
Mkt Cap
805.56M
P/E Ratio
21.47
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Dec 2020
€0.53
Aug 2019
€0.25
Apr 2019
€0.36
Dec 2018
€0.25
Aug 2018
€0.25
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Financials

9.47%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
55.64MRevenue
5.27MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

NIBC Holding N.V. provides corporate and retail banking products and services in the Netherlands, Germany, Belgium, the United Kingdom, and the Nordics. It operates through Corporate Client Offering, Retail Client Offering, and Treasury and Group Functions segments. The company offers merger and acquisition advisory services; equity sales and trading; debt and equity advisory services; leveraged and receivables finances; corporate lending; asset and cash flow finance; and project equity services. The company also offers mezzanine and equity solutions; and equities research, fixed income, and debt and equity capital market services. In addition, it provides mortgages; and savings products, as well as brokerage services under the NIBC Direct label. The company serves corporate clients, financial institutions, institutional investors, financial sponsors, family offices, entrepreneurial investors, and retail clients. NIBC Holding N.V. was founded in 1945 and is headquartered in The Hague, the Netherlands. As of December 21, 2020, NIBC Holding N.V. operates as a subsidiary of The Blackstone Group International Partners LLP.
Show More
CEO
Mr. Paulus A. M. de Wilt
Employees
726
Country
Other
ISIN
BG1100008074
WKN
000A14SWU

Listings

0 Comments

Share your thoughts

FAQs

What is Tchaikapharma Highquality Medicines AD stock price today?▼
The current price of 4NH.F is €8.40 EUR — it has increased by +1.82% in the past 24 hours. Watch Tchaikapharma Highquality Medicines AD stock price performance more closely on the chart.
What is Tchaikapharma Highquality Medicines AD stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Tchaikapharma Highquality Medicines AD stocks are traded under the ticker 4NH.F.
What is Tchaikapharma Highquality Medicines AD market cap?▼
Today Tchaikapharma Highquality Medicines AD has the market capitalization of 805.56M
What is Tchaikapharma Highquality Medicines AD revenue for the last year?▼
Tchaikapharma Highquality Medicines AD revenue for the last year amounts to 55.64M EUR.
What is Tchaikapharma Highquality Medicines AD net income for the last year?▼
4NH.F net income for the last year is 5.27M EUR.
Does Tchaikapharma Highquality Medicines AD pay dividends?▼
Yes, 4NH.F dividends are paid semi-annual. The last dividend per share was 0.53 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Tchaikapharma Highquality Medicines AD have?▼
As of November 2, 2026, the company has 726 employees.
In which sector is Tchaikapharma Highquality Medicines AD located?▼
Tchaikapharma Highquality Medicines AD operates in the Finance & Payments sector.
When did Tchaikapharma Highquality Medicines AD complete a stock split?▼
The last stock split for Tchaikapharma Highquality Medicines AD was on July 8, 2025 with a ratio of 1.0446623:1.
Where is Tchaikapharma Highquality Medicines AD headquartered?▼
Tchaikapharma Highquality Medicines AD is headquartered in The Hague, Other.